| 000 | 01414 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517135250.0 | ||
| 264 | 0 | _c20190521 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1615-6692 | ||
| 024 | 7 |
_a10.1007/s00059-017-4537-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYousif, N G | |
| 245 | 0 | 0 |
_aCardioprotective effects of irbesartan in polymicrobial sepsis : The role of the p38MAPK/NF-κB signaling pathway. _h[electronic resource] |
| 260 |
_bHerz _cMar 2018 |
||
| 300 |
_a140-145 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCoinfection _xblood |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aIrbesartan _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPremedication |
| 650 | 0 | 4 |
_aSepsis _xblood |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 700 | 1 | _aHadi, N R | |
| 700 | 1 | _aAl-Amran, F | |
| 700 | 1 | _aZigam, Q A | |
| 773 | 0 |
_tHerz _gvol. 43 _gno. 2 _gp. 140-145 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00059-017-4537-6 _zAvailable from publisher's website |
| 999 |
_c26836989 _d26836989 |
||